What If Fast Had Supanova? The $120M Checkout Startup That Couldn't Scale
The Letter Every Founder Dreads Writing
On April 5, 2022, Domm Holland posted a letter to Medium that every founder should read twice.
"Today is a difficult day," it began. "I've made the incredibly difficult decision to shut down Fast."
The letter talked about innovation. About timing. About being "too far ahead of the market." It was gracious, reflective, appropriately mournful. The kind of shutdown announcement that respects employees, thanks investors, and maintains dignity in defeat.
Here's what the letter didn't say:
Fast was spending $10 million per month while generating $600,000 in revenue. They'd raised $120M in eighteen months and hired 400 people to build one-click checkout for the internet. Somewhere in that bonfire of capital, they spent $1 million on a concert with The Chainsmokers—a performance for their own employees while the company burned through cash faster than any metric could track.
This isn't a story about excess. It's a story about suffocation.
About what happens when growth velocity exceeds cognitive capacity. When humans try to make decisions at machine speed. When you're moving so fast that by the time you realize you're dying, you've already run out of runway.
We call it Hypergrowth Hypoxia Syndrome. And if you've raised a Series A or B in the last 24 months, you might have it too.
The Disease That Destroyed Fast
Hypergrowth Hypoxia Syndrome: A Clinical Diagnosis
Definition: The fatal condition where startups scale headcount, spending, and promises faster than they can scale systems, controls, and actual capabilities—resulting in organizational suffocation despite abundant capital.
Think of it like altitude sickness for startups. When climbers ascend too quickly without acclimatization, their bodies can't process oxygen fast enough. Judgment becomes impaired. Simple decisions feel impossible. Summit fever sets in—the obsessive drive to reach the peak no matter the cost.
Fast experienced textbook HHS. Here's how the disease progressed:
Stage 1: Capital Infusion Creates Altitude Sickness
- September 2020: $20M Series A
- January 2021: $102M Series B led by Stripe
- Valuation climbs to $580M
- Board pressure to "show scale" intensifies
- Growth mandate becomes non-negotiable
Stage 2: Rapid Scaling Depletes Operational Oxygen
- January 2021: 90 employees
- December 2021: 400 employees (4.4x growth in 12 months)
- Each new hire requires onboarding, management, coordination
- Systems can't scale as fast as headcount
- Information flow breaks down
- Questions take weeks to answer
Stage 3: Leadership Experiences Impaired Judgment
- $1M concert with The Chainsmokers (hypoxic decision #1)
- Aggressive enterprise push without qualification system (hypoxic decision #2)
- Targeting PayPal as competitor while ignoring Bolt (hypoxic decision #3)
- Continuing to hire despite no revenue traction (hypoxic decision #4)
- Custom engineering per merchant instead of standardized integration (hypoxic decision #5)
Stage 4: Organ Failure Begins
- Sales team can't close enterprise deals
- Customer success can't support onboarded merchants
- Product integrity deteriorates ("spotty at best")
- Integration timelines stretch to 6-8 weeks per merchant
- Only ONE enterprise customer onboarded before shutdown
Stage 5: Sudden Collapse Despite "Healthy" Appearance
- March 2022: Still 400 employees, still funded
- April 5, 2022: Shutdown announcement
- No time for course correction
- No runway left for experimentation
- The end came suddenly because the warning signs were invisible
The Symptoms Checklist
Take 60 seconds. How many of these apply to your company right now?
Financial Symptoms:
- Monthly burn exceeds revenue by 10x or more
- You can't answer "Which customers are profitable?" in under 24 hours
- Last financial model took 2+ weeks to build and is already outdated
- Spending anomalies (unusual expenses) go undetected for weeks
- You don't know your exact runway without opening a spreadsheet
Operational Symptoms:
- Dashboard requests take 1+ weeks to fulfill
- You can't explain where half your budget goes
- "How many of our employees drive revenue?" has no clear answer
- Integration/onboarding timelines keep extending
- Customer support doesn't scale with customer count
Strategic Symptoms:
- You're targeting the wrong competitor (the big name, not the real threat)
- Sales team chases every lead because you need to "show traction"
- Decisions get made based on gut feelings, not data (because data takes too long)
- You've made at least one decision in the last 6 months that you'd never make "at sea level"
- When asked "What would you cut if you had to reduce spend 40%?" you genuinely don't know
Cognitive Symptoms:
- Simple questions take days or weeks to answer
- You're moving too fast to measure what's working
- Strategic planning feels impossible because market moves faster than your analysis
- You secretly wonder if you're building on quicksand
- Sleep quality correlates inversely with growth rate
Your HHS Risk Score:
- 0-4: Low risk - You have operational controls
- 5-9: Moderate risk - Monitor closely, consider adding systems
- 10-14: High risk - Fast was here 12 months before shutdown
- 15-20: Critical risk - Fast was here 3 months before shutdown
If you scored 10+, keep reading. This is written for you.